Compare LTC & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTC | GRDN |
|---|---|---|
| Founded | 1992 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail-Drug Stores and Proprietary Stores |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 1992 | 2024 |
| Metric | LTC | GRDN |
|---|---|---|
| Price | $36.45 | $29.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $39.00 | $32.00 |
| AVG Volume (30 Days) | ★ 432.2K | 367.3K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | ★ 6.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | 0.28 |
| Revenue | $226,987,000.00 | ★ $1,389,638,000.00 |
| Revenue This Year | N/A | $16.33 |
| Revenue Next Year | $13.01 | $2.10 |
| P/E Ratio | ★ $50.60 | $105.04 |
| Revenue Growth | 14.23 | ★ 18.68 |
| 52 Week Low | $31.70 | $17.78 |
| 52 Week High | $39.15 | $37.43 |
| Indicator | LTC | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 59.33 | 56.99 |
| Support Level | $35.50 | $27.60 |
| Resistance Level | $36.92 | $30.00 |
| Average True Range (ATR) | 0.57 | 1.74 |
| MACD | 0.06 | -0.11 |
| Stochastic Oscillator | 69.72 | 19.00 |
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.